Vimarsana
Biggest News Aggregation in the World

Page 33 - Johnson Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnson Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnson Medtech Today - Breaking & Trending Today

AdvaMed Launches New Digital Health Tech Division, Appoints Board Members - Vimarsana News

AdvaMed Launches New Digital Health Tech Division, Appoints Board Members

AdvaMed, the Medtech Association, announced the formation of AdvaMed Digital Health Tech, a new division within the organization that represents digital medical technology companies and promotes the critical role of data and digital medtech in transforming health care. The group, which is led by Shaye Mandle, acts as a thought leader and convener for the industry and focuses on four core policy areas: regulation, payment and health care delivery, data stewardship and privacy, and cybersecu...

DePuy Synthes' new spine system earns FDA clearance - Vimarsana News

DePuy Synthes' new spine system earns FDA clearance

DePuy Synthes, Johnson and Johnson's orthopedic company, earned FDA 510(k) clearance for the TriALTIS spine system.

J&J's DePuy Synthes wins FDA clearance for TriAltis tech - Vimarsana News

J&J's DePuy Synthes wins FDA clearance for TriAltis tech

Johnson & Johnson MedTech announced today that its DePuy Synthes unit won FDA 510(k) clearance for two TriAltis technologies.

Orange County students get hands-on opportunities for National Manufacturing Day - Vimarsana News

Orange County students get hands-on opportunities for National Manufacturing Day

To mark National Manufacturing Day, Orange County nonprofit Vital Link brought its students to an expansive tour of Johnson & Johnson MedTech in Irvine.

Biosense Webster Study Links Lower Risk of Heart Failure in Atrial Fibrillation Patients Treated with Catheter Ablation Compared to Antiarrhythmic Drugs - Vimarsana News

Biosense Webster Study Links Lower Risk of Heart Failure in Atrial Fibrillation Patients Treated with Catheter Ablation Compared to Antiarrhythmic Drugs

Retrospective study of over 18,000 drug-refractory AFib patients found those treated with catheter ablation had a 57% lower risk of developing heart failure compared to those receiving antiarrhythmic drugs